Format

Send to

Choose Destination
See comment in PubMed Commons below
Neurochem Int. 2007 Feb;50(3):524-30. Epub 2006 Dec 4.

Comparison of doxycycline and minocycline in the inhibition of VEGF-induced smooth muscle cell migration.

Author information

1
Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California-San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA.

Abstract

Smooth muscle cell migration plays an important role during angiogenesis and vascular remodeling. In this study, we examined the effects of doxycycline and minocycline on vascular endothelial growth factor (VEGF)-induced human aortic smooth muscle cell (HASMCs) migration, and explored the mechanisms in which doxycycline or minocycline inhibit HASMC migration. We demonstrated that both doxycycline and minocycline attain consistent anti-angiogenic effects in the inhibition of HASMC migration via a different signal pathway (p<0.05). This effect is through attenuating VEGF-induced matrix metalloproteinase-9 (MMP-9) activity (p<0.05). Doxycycline could increase tissue inhibitors of metalloproteinases-1 (TIMP-1) expression while minocycline down-regulated PI3K/Akt phosphorylation in HASMC. Our study suggests that doxycycline has a stronger ability to inhibit MMP secretion in HASMC by up-regulating endogenous MMPs inhibitor TIMP-1, while minocycline implements anti-angiogenic effect through inhibiting HASMC migration by down-regulating PI3K/Akt pathway.

PMID:
17145119
PMCID:
PMC1876824
DOI:
10.1016/j.neuint.2006.10.008
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center